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Abstract
Background:  PCR inhibition by nucleic acid extracts is a well known yet poorly described
phenomenon. Inhibition assessment generally depends on the assumption that inhibitors affect all
PCR reactions to the same extent; i.e. that the reaction of interest and the control reaction are
equally susceptible to inhibition. To test this assumption we performed inhibition assessment on
DNA extracts from human urine samples, fresh urine and EDTA using different PCR reactions.
Results: When copurified inhibitors were assessed using two different PCR reactions one reaction
appeared to be inhibited whilst the other was not. Further experiments using various
concentrations of unextracted urine to inhibit six different PCR reactions revealed that
susceptibility to inhibition was highly variable between reactions. Similar results were obtained
using EDTA as the PCR inhibitor. We could find no obvious explanation why one reaction should
be more susceptible to inhibition than another, although a possible association with amplicon GC
content was noted.
Conclusion: These findings have serious implications for all PCR-based gene expression studies,
including the relatively new PCR array method, and for both qualitative and quantitative PCR-based
molecular diagnostic assays, suggesting that careful consideration should be given to inhibition
compatibility when conducting PCR analyses. We have demonstrated unequivocally that it is not
safe to assume that different PCR reactions are equally susceptible to inhibition by substances co-
purified in nucleic acid extracts.
Background
It is well known that the polymerase chain reaction (PCR)
is susceptible to inhibitors [1-4] and many publications
describe methods for assessing inhibition using spiked
alien molecules of various types [5-9]. Inhibition in real-
time PCR can be measured as the increase in threshold
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cycle (Ct) or crossing point (Cp) relative to an uninhib-
ited control [10]. The presence of inhibitors has the
potential to increase error, reduce assay resolution, and
produce false results in both quantitative and qualitative
PCR assays. Direct assessment of inhibition is not usually
performed [1], but as real-time PCR analyses frequently
include additional reactions to control for sample varia-
tion (normalisation) by measuring reference 'housekeep-
ing' transcripts [11] or genomic DNA [12], an assessment
of, and compensation for, inhibition is often conducted
indirectly.
Using a spiked alien molecule (as an internal positive con-
trol) or reference gene to assess inhibition relies on the
fundamental assumption that any inhibitor present
within the sample will have an equal effect on both PCR
reactions. However, there appears to be no evidence in the
literature to substantiate this assumption. Intuitively,
there is no fundamental reason why this assumption
should be valid, and yet it underpins a significant propor-
tion of the PCR analyses performed daily in research and
diagnostic laboratories throughout the world. In this
study we examine, using a model system, how a range of
different reactions may be differentially affected by PCR
inhibitors and discuss the implications of the unexpected
findings.
Methods
For more detailed methods please refer to the additional
file.
Urine donors
Fresh mid stream urine specimens were collected from 19
healthy adult volunteers. An aliquot from each specimen
was cultured to exclude the presence of bacterial infection.
Written informed consent was obtained from all partici-
pants and the appropriate hospital ethics committee
approved the study.
DNA extraction from urine
DNA was extracted from 10 ml urine using a protocol
combining Q-sepharose™ Fast Flow (GE Healthcare Life
Sciences, Buckinghamshire, UK) and a Viral RNA Mini Kit
(Qiagen, Crawley, UK). DNA was eluted in 50 μl water
and 5 μl of this used for the respective PCR reactions.
Real-time PCR
Six real-time PCR reactions were used in this study as
detailed in Tables 1 and 2. The SPUD [8], PjHSP70a [12]
and IS1081 [13] reactions have been previously described.
All reactions were conducted in 12.5 μl volumes using
QuantiTect Probe PCR kit 2 × master mix (Qiagen, Craw-
ley, UK) and a Rotorgene 6000 thermocycler (Corbett
Research, Cambridge, UK). PCR efficiencies were esti-
mated using ten fold dilution series according to the for-
mula E = 10(-1/slope)-1 [14]. Amplification curves were also
assessed to establish what effect potential inhibitors had
on gradient and endpoint fluorescence.
Inhibition assessment method
In all experiments the appropriate spiked molecule was
included at ~1000 copies/reaction. Inhibition was
assessed by comparing the Ct of the control reaction to
Table 1: Primer and probe sequences
Reaction Oligoδ Sequence
PjHSP70a F CGTCTTGTAAACCACTTCATTGC
R AGTCCGTTTAGCACGCTCAC
P HEX 5' AAGAAAGATCTTTCAGGG 3' BHQ1*
mtLSU133 F GCACTGAATATCTCGAGGGA
R ACTGTTCTGGGCTGTTTCC
P HEX 5' CTTATCGCACATAGTCTGATT 3'BHQ1*
CFP32 F AGAAGCGAATACAGGCAAGG
R CGGACTGATCGGTGGTCT
P HEX 5' CGCCGAACTGGGTCGACCTTC 3' BHQ1
IS1081 F CTGCTCTCGACGTTCATCGCCG
R GGCACGGGTGTCGAAATCACG
P HEX 5' ATTGGACCGCTCATCGCTGCGTTCGC 3' BHQ1
16S MTb F CAAGTCGAACGGAAAGGTCT
R GCAGATCACCCACGTGTTAC
P HEX 5' CCCGTTCGCCACTCGAGTATCTC 3' BHQ1
SPUD F AACTTGGCTTTAATGGACCTCCA
R ACATTCATCCTTACATGGCACCA
P FAM 5'TGCACAAGCTATGGAACACCACGT 3' BHQ1
n.b. δ Oligos; F: forward primer, R: reverse primer, P: hydrolysis probe.
* underline denotes locked nucleic acid (LNA) moietiesBMC Research Notes 2008, 1:70 http://www.biomedcentral.com/1756-0500/1/70
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which RNAse/DNAse-free water (Sigma, Cambridge, UK)
had been added with the Ct of the reaction to which the
potential inhibitor had been added. Inhibition was
expressed as increase in Ct or as reduction in reported
copy number.
Inhibitory samples
DNA extracts from 19 urine samples were used to investi-
gate inhibition of the SPUD and mtLSU133 PCR reac-
tions. Unextracted urine also obtained from a single
healthy male volunteer was used to investigate inhibition
of all six PCR reactions. Unextracted urine was added
directly to the PCR reactions to comprise 4%, 6.6%, 8%,
10%, 13.3%, 20% or 40% of the total reaction volume. In
addition EDTA was used to investigate whether limiting
free Mg2+ would have a similar inhibitory effect on the
respective reactions as unextracted urine. PCR reactions
were performed as described above with the addition of
1.0, 1.25, 1.5, 2.0, 2.5 or 4.0 mM EDTA to each reaction.
All experimentally inhibited reactions were performed in
triplicate.
Statistical analysis and amplicon characterisation
Statistical comparisons were made using the t test. Primer
and amplicon sequences were assessed for size, GC con-
tent and secondary structure to establish if there were any
sequence characteristics predictive of the degree of suscep-
tibility to inhibition. Amplicon secondary structure was
analysed using Mfold [15]. Primers were further assessed
for Tm, 3' end stability, enthalpy, entropy and free energy,
calculated by the nearest neighbour method [16] using
NetPrimer software (Premier Biosoft International).
Results
Inhibition by urine extracts
15 of the 19 urine extracts caused an increase in Ct of > 0.5
cycle with the mtLSU133 reaction whereas only one of the
extracts caused such a Ct increase with the SPUD reaction.
There was no significant difference between the SPUD
control reactions and the SPUD reactions to which urine
extracts had been added (Figure 1A). However, there was
a 1.9 fold decrease (p = < 0.0001, 95% confidence inter-
vals 0.6 fold to 3.3 fold decrease) in the average copy
number of the mtLSU133 extract reactions when com-
pared with the mtLSU133 control reactions (Figure 1B).
Thus the mtLSU133 PCR appeared to be susceptible to
inhibition by urine extracts whilst the SPUD PCR reaction
was not.
Inhibition by unextracted urine
To further investigate PCR reaction susceptibility to inhi-
bition, different quantities of unextracted urine were used
to simulate inhibition. When three different PCR reac-
tions (mtLSU133, SPUD and PjHSP70) were investigated
there was always a positive correlation between the per-
centage of urine and the Ct value. Unextracted urine com-
prising 20% and 40% of the reaction volume totally
inhibited all PCRs. When lower percentages of urine were
used, the degree of inhibition was found to be reaction
specific. The SPUD reaction was least affected by inhibi-
tion, the mtLSU133 reaction was most affected, with the
PjHSP70 reaction intermediate (Figure 2).
The effect of unextracted urine at 10% and 13.3% of the
reaction volume was also investigated in three additional
PCR reactions, 16S, CFP32 and IS1081. The results are
summarised together with those generated by mtLSU133,
SPUD and PjHSP70 PCRs, in Figure 3. Different degrees of
susceptibility to inhibition were displayed by each of the
different PCR reactions. This was most clearly illustrated
by the fact that 10% urine had no inhibitory effect on the
IS1081 reaction whilst completely inhibiting the
mtLSU133 reaction.
Inhibition by ethylenediaminetetraacetic acid (EDTA)
To establish whether lowering the free Mg2+ would have a
similar differential inhibitory effect, the SPUD, PjHSP70a
and mtLSU133 reactions were performed in the presence
of different concentrations of EDTA. 4 mM EDTA com-
pletely inhibited all reactions (data not shown). Lower
concentrations of EDTA produced varying degrees of inhi-
bition that, once again, were reaction specific. The order
Table 2: PCR reaction parameters
Reaction parameters
Assay F & R 
[Primer]
[Probe] Annealing 
temp
95°C Anneal 72°C Wavelength 
excite/acquire
PjHSP70a 600 nM 200 nM 60°C 10 sec 10 sec 20 sec 530 nm/555 nm
mtLSU133 700 nM 100 nM 56°C 10 sec 20 sec 20 sec 530 nm/555 nm
CFP32 600 nM 75 nM 60°C 10 sec 20 sec 16 sec 530 nm/555 nm
IS1081 600 nM 75 nM 60°C 10 sec 20 sec 16 sec 530 nm/555 nm
16S MTb 600 nM 200 nM 60°C 10 sec 20 sec 20 sec 530 nm/555 nm
SPUD 600 nM 200 nM 56°C 10 sec 10 sec 20 sec 470 nm/510 nmBMC Research Notes 2008, 1:70 http://www.biomedcentral.com/1756-0500/1/70
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of susceptibility to inhibition (mtLSU133 > PjHSP70a >
SPUD) was the same as that observed with unextracted
urine (Figure 4).
Effect of inhibition on curve gradient and endpoint 
fluorescence
Inhibition associated with urine extracts, unextracted
urine or EDTA always resulted in a reduction in the steep-
ness of the amplification curve gradient and an associated
reduced endpoint fluorescence that was inversely corre-
lated with Ct (Figure 5).
Amplicon characteristics and susceptibility to inhibition
There was no consistent correlation across the six PCR
reactions between susceptibility to inhibition and any of
the primer or amplicon characteristics analysed including
size, Tm, GC content, secondary structure, 3' end stability,
enthalpy, entropy and free energy (Table 3). Despite the
lack of a consistent or statistically significant correlation
across all six reactions, it was noted that the PCR with the
greatest susceptibility to inhibition (mtLSU133) gener-
ated the amplicon with the lowest GC content (32.3%)
and had the lowest primer Tms, whereas the PCR that was
least susceptible to inhibition (IS1081) generated the
amplicon with the highest GC content (67.4%) and had
the highest primer Tms. However, this trend was not
maintained for PCRs with intermediate susceptibilities to
inhibition.
Discussion
Co-purification of inhibitors of PCR during nucleic acid
extraction is a well recognised phenomenon [17,2-4] that
can be caused by numerous substances [18,19]. The
present study demonstrates that these inhibitors can have
different effects on different PCR reactions, and that these
differential effects can be concentration dependent. The
latter point is particularly relevant as the actual concentra-
tion of a co-purified inhibitor is usually unknown.
The effect of reaction specific inhibition can be relatively
subtle although statistically significant, as demonstrated
here using urine extracts (Figure 1). In contrast, more dra-
matic effects may be seen at higher concentrations of
inhibitor, as illustrated in Figures 2 &3. It is possible for
one PCR reaction to be unaffected by a potential inhibitor
whilst another is completely suppressed. If two different
PCR reactions are to be compared, or one is to be used as
a reference reaction for the other, as in the 'normalisation'
procedure commonly used in quantitative gene expres-
sion studies [11], it is important that the two reactions are
affected by potential inhibitors to the same extent; we
describe this as inhibition compatibility. Recognition of the
Effect of urine extracts on copy number measured by A) SPUD and B)  mtLSU133 PCR reactions. Figure 1
Effect of urine extracts on copy number measured by A) SPUD and B)  mtLSU133 PCR reactions.BMC Research Notes 2008, 1:70 http://www.biomedcentral.com/1756-0500/1/70
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Effect of urine concentration on threshold cycle (Ct) for three different real-time PCR reactions Figure 2
Effect of urine concentration on threshold cycle (Ct) for three different real-time PCR reactions. n.b. Data plot-
ted as median ± highest and lowest (triplicate reaction), failure of reaction to amplify is represented graphically by a Ct of 45.
Effect of adding 0%, 10% or 13.3% urine on copy number for six different real-time PCR reactions Figure 3
Effect of adding 0%, 10% or 13.3% urine on copy number for six different real-time PCR reactions. Failure of reac-
tion to amplify is represented graphically as zero copies.BMC Research Notes 2008, 1:70 http://www.biomedcentral.com/1756-0500/1/70
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importance of assessing inhibition compatibility should
contribute to reducing error and increasing accuracy in
both gene expression studies and PCR-based molecular
diagnostics. Inhibition incompatibility is likely to have a
major effect on recent developments in the field, like mul-
tiplexed tandem PCR [20] and PCR arrays [21], that aim
to allow many PCR reactions to be performed on a single
sample.
Susceptibility of a PCR reaction to inhibitors is an impor-
tant factor influencing the robustness of an assay that
should be considered during experimental design. If dif-
ferent reactions are to be compared then they need to be
of similar robustness, i.e. to be inhibition compatible.
These observations lead to the question of how inhibition
compatibility can be measured. An initial approach
would be to perform inhibition assessment for the rele-
vant PCR reactions in the presence of different concentra-
tions of EDTA, as described in the present study. This is a
simple strategy but it assumes that all potential inhibitors
will have the same effect on the respective reactions as
EDTA. The results obtained here using EDTA suggest that
a PCR reaction that is more susceptible to inhibition by
depletion of free Mg2+ may also be more susceptible to
inhibition by urine or urine extracts. This implies that the
inhibitors present in urine might also be acting by deple-
tion of free Mg2+, although this remains uncertain. Per-
haps a more thorough approach would be to assess the
relevant PCR reactions for inhibition using a range of con-
centrations of several well known inhibitors such as
heparin and ethanol in addition to EDTA. Ideally, nucleic
acid extracts from the sample types of interest (assuming
they are known not to contain the PCR target) should also
be tested for their inhibitory potential with the relevant
PCR reactions but this may not always be feasible.
Ideally, it would be possible to design PCR reactions to be
inhibition compatible and to minimise inhibition suscep-
tibility. Unfortunately, the findings of this study have not
revealed any primer, or amplicon parameter that is relia-
bly and consistently associated with susceptibility to inhi-
bition, although we can tentatively suggest that amplicon
GC content and primer Tm may be significant factors.
While it is unlikely that there is a single simple factor that
can be manipulated in experimental design to ensure
inhibitor compatibility there are a number of general
measures that can be taken to minimise the problem.
These measures include the careful selection of type of
thermostable DNA polymerase [22], reduction in the
amount of DNA template added to the reaction and the
use of certain additives such as bovine serum albumin,
which provide some resistance to inhibitors that may be
present in blood [23]. Increasing the denaturation time
can also reduce the susceptibility to inhibition in certain
cases (data not shown).
The effect of EDTA concentration on different qPCR reactions Figure 4
The effect of EDTA concentration on different qPCR reactions n.b.  Data plotted as median ± highest and lowest 
(triplicate reaction), failure of reaction to amplify is represented on graph by a Ct of 45. The control reactions without addition 
of EDTA gave a Ct value of 28 cycles.BMC Research Notes 2008, 1:70 http://www.biomedcentral.com/1756-0500/1/70
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The effect of adding 4 %, 6.6 %, 10 % and 13.3 % urine on the amplification curve gradient and endpoint fluorescence of the  SPUD PCR reaction. Figure 5
The effect of adding 4 %, 6.6 %, 10 % and 13.3 % urine on the amplification curve gradient and endpoint fluores-
cence of the SPUD PCR reaction. Background normalised data plotted using Rotor-gene 6000 series software (Corbett 
Research, Cambridge, UK).BMC Research Notes 2008, 1:70 http://www.biomedcentral.com/1756-0500/1/70
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Conclusion
The findings of this study tackle an area that is frequently
overlooked when conducting PCR. Whilst we acknowl-
edge that our experiments use an unusual approach, as
unextracted urine is not routinely used in PCR reactions
(although unextracted urine has recently been used for
viral genome detection [24]), the results illustrate an
important principle. Users should be aware that co-puri-
fied inhibitors in nucleic acid extracts may not affect all
PCR reactions equally and this fact must be taken into
account when considering sample choice, experimental
design and data interpretation.
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